2024 Expert Speaker Faculty

Catja Freiburghaus

Senior Scientist, Clinical Development Lead Gene Therapy

Hansa Biopharma

David Barrett

Chief Executive Officer

ASGCT

Dawn Phillips

Senior Director Clinical Outcomes Research

REGENXBIO

Edward Neilan

Chief Medical and Scientific Officer

National Organization for Rare Disorders (NORD)

Eric Zheng

Principal Scientist

Prime Medicine

Greg Luerman

Vice President - Research & Partnerships

Curi Bio

HEATHER FITZPATRICK MEDLIN

Sr, Director

CureDuchenne

James Warren

Senior Vice President - Pharmaceutical Development

Ultragenyx

Jamie Marshall

Principal Scientist

Solid Biosciences

Jan Panteli

Director, Upstream Process Development, Gene Therapy

Ultragenyx

Jenn McNary

Co-Founder

Canary Advisors LLC

Jesse Marshall

Research Scientist/Patient Parent

Reality Labs

Kathy Ivey

Vice President - Gene Therapy & Research

Tenaya Therapeutics

Kristin Stephenson

Director - Office of Strategy & Alliances, Pediatric Translational Neuroscience Initiative

St. Jude Children's Research Hospital

Lena Winstedt

Global Franchise Lead Gene Therapy

Hansa Biopharma

Lianna Orlando

Vice President - Research & Partner

CureDuchenne

Melissa Wong

Partner

Holland & Knight

Michelle Rengarajan

Instructor in Medicine/Patient Parent

Harvard Medical School

Mindy Cameron

President

AdvocacyWorks

Mitra Tavakkoli

Vice President - Clinical Development

Formerly of 4D Molecular Therapeutics

Morten Sogaard

President & Divison Head of Gene Therapy Research & Technical Operations

Astellas Gene Therapies

Richard Parad

Director, Newborn Genomics Program

Brigham Women's Hospital

Sharif Tabebordbar

Chief Scientific Officer

Kate Therapeutics

Sonia Albini

Research & Development Scientist

Genethon